BMRN icon

BioMarin Pharmaceuticals
BMRN

Overview Fund Activity

321 hedge funds and large institutions have $8.94B invested in BioMarin Pharmaceuticals in 2014 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 128 increasing their positions, 103 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
321
Holders Change
+8
Holders Change %
+2.56%
% of All Funds
9.23%
Holding in Top 10
11
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+37.5%
% of All Funds
0.32%
New
45
Increased
128
Reduced
103
Closed
36
Calls
$140M
Puts
$100M
Net Calls
+$40.2M
Net Calls Change
+$53.1M

Top Buyers

1
Sands Capital Management
Sands Capital Management
Virginia
$742M
2
Fidelity Investments
Fidelity Investments
Massachusetts
$573M
3
Millennium Management
Millennium Management
New York
$86.4M
4
Norges Bank
Norges Bank
Norway
$139M
5
WRF
Waddell & Reed Financial
Kansas
$99.3M

Top Sellers

1
Winslow Capital Management
Winslow Capital Management
Minnesota
$6K
2
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
$660K
3
Jennison Associates
Jennison Associates
New York
$333M
4
Capital World Investors
Capital World Investors
California
$0
5
HCM
Holland Capital Management
Illinois
$46.2M
Name Holding Trade Value Shares
Change 		Shares
Change %
OC
351
Oppenheimer & Co
New York
– -$219K -3,214 Closed
DTL
352
Dynamic Technology Lab
Singapore
– -$214K -3,139 Closed
MC
353
Mathes Company
New York
– -$201K -2,950 Closed
Robeco Institutional Asset Management
354
Robeco Institutional Asset Management
Netherlands
– -$53K -775 Closed
M&T Bank
355
M&T Bank
New York
– -$8K -119 Closed
HR
356
Howe & Rusling
New York
– -$6K -81 Closed
KT
357
Kanaly Trust
Texas
– -$1K -18 Closed
ST
358
SpiderRock Trading
Illinois
– -$33K – –
11 12 13 14
15